As expected, overexpression of PHLPP2 significantly increased ROS levels in CRC cells, and the proportion of CD133+ cells in the Lv-PHLPP2 group was significantly lower than that in the Lv-Cont group. This evidence concerns the gene PROM1 and colorectal carcinoma.